top of page

THE RESEARCH

MouseAsset 7_4x_edited.png
Asset 32_4x_edited.png

Understanding how drug targets work – thus, how future drugs could work – is instrumental across disease. Despite major advances in our understanding of human biology, the average failure rate of drugs following clinical trials surpasses 90%. Many successful drugs target receptors, as membrane proteins that detect extracellular stimuli and evoke intracellular responses. Many pharmacologists have, however, focused on G protein-coupled receptors (GPCRs) due to their small size. The Peach lab sets out to account for every player in the team.

Receptor Tyrosine Kinases

RTKs are a family of 58 membrane proteins that respond to growth factors. These large ligands trigger signalling cascades that lead to cell proliferation, avoidance of cell death and initiation of migratory processes. They are therefore major clinically-approved targets in cancer. RTKs are, however, dynamic signalling hubs with wide-reaching pathological implications that are yet to be exploited. 

The local cellular microenvironment

Receptors are often considered as single entities in isolation from their local context. Receptors are, however, surrounded by many seemingly ‘invisible’ components of a human cell. Thousands of distinct molecules are crowded together:- neighbouring proteins, invaginations of the plasma membrane undergoing endocytosis, a myriad of intracellular avenues formed by the cytoskeleton or extensive glycan networks that establish the extracellular matrix (ECM). As well as being major ‘signalling hubs’, RTKs travel around cells via increasingly acidic vesicles following endocytosis. The dynamic nature of receptor trafficking will therefore expose RTKs to a range of distinct biochemical microenvironments. The Peach laboratory is interested in how the unique local microenvironment of a receptor modulates their pharmacology.

Microenvironment

The Peach lab sets out to ask: 

​

  • ​Are RTKs modulated by components in their local microenvironment - proteome and beyond - that differ in disease?

  • How are the dynamics of RTK pharmacology regulated in distinct subcellular compartments?

  • Can we target RTKs therapeutically beyond oncology, from chronic pain to neurodegenerative disease?

Address

D18/D19

Queen's Medical Centre, 

School of Life Sciences,

Nottingham, U.K.

NG7 2UH

University Website

Phone

+44 115 823 0114

Connect

© 2023 by Peach Labs. Designed by Wix.

bottom of page